These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22178593)

  • 1. Growth factor delivery systems and repair strategies for damaged peripheral nerves.
    Madduri S; Gander B
    J Control Release; 2012 Jul; 161(2):274-82. PubMed ID: 22178593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve conduits and growth factor delivery in peripheral nerve repair.
    Pfister LA; Papaloïzos M; Merkle HP; Gander B
    J Peripher Nerv Syst; 2007 Jun; 12(2):65-82. PubMed ID: 17565531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve conduit scaffolds for discrete delivery of two neurotrophic factors.
    Catrina S; Gander B; Madduri S
    Eur J Pharm Biopharm; 2013 Sep; 85(1):139-42. PubMed ID: 23958324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trophically and topographically functionalized silk fibroin nerve conduits for guided peripheral nerve regeneration.
    Madduri S; Papaloïzos M; Gander B
    Biomaterials; 2010 Mar; 31(8):2323-34. PubMed ID: 20004018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in glial cell line-derived neurotrophic factor release from biodegradable nerve conduits modify the rate of functional motor recovery after rat primary nerve repairs.
    Piquilloud G; Christen T; Pfister LA; Gander B; Papaloïzos MY
    Eur J Neurosci; 2007 Sep; 26(5):1109-17. PubMed ID: 17767490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration.
    Madduri S; Gander B
    J Peripher Nerv Syst; 2010 Jun; 15(2):93-103. PubMed ID: 20626772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factors-based therapeutic strategies and their underlying signaling mechanisms for peripheral nerve regeneration.
    Li R; Li DH; Zhang HY; Wang J; Li XK; Xiao J
    Acta Pharmacol Sin; 2020 Oct; 41(10):1289-1300. PubMed ID: 32123299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in artificial nerve conduit design: strategies for the delivery of luminal fillers.
    Pabari A; Yang SY; Mosahebi A; Seifalian AM
    J Control Release; 2011 Nov; 156(1):2-10. PubMed ID: 21763371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen nerve conduits releasing the neurotrophic factors GDNF and NGF.
    Madduri S; Feldman K; Tervoort T; Papaloïzos M; Gander B
    J Control Release; 2010 Apr; 143(2):168-74. PubMed ID: 20035811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve repair: experimental and clinical evaluation of neurotrophic factors in peripheral nerve regeneration.
    Johnson EO; Charchanti A; Soucacos PN
    Injury; 2008 Sep; 39 Suppl 3():S37-42. PubMed ID: 18723170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress of electrospun fibers as nerve conduits for neural tissue repair.
    Mu Y; Wu F; Lu Y; Wei L; Yuan W
    Nanomedicine (Lond); 2014; 9(12):1869-83. PubMed ID: 25325242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of peripheral nerve regeneration: interactions at the axon level.
    Allodi I; Udina E; Navarro X
    Prog Neurobiol; 2012 Jul; 98(1):16-37. PubMed ID: 22609046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silk fibroin matrices for the controlled release of nerve growth factor (NGF).
    Uebersax L; Mattotti M; Papaloïzos M; Merkle HP; Gander B; Meinel L
    Biomaterials; 2007 Oct; 28(30):4449-60. PubMed ID: 17643485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits.
    Pfister LA; Alther E; Papaloïzos M; Merkle HP; Gander B
    Eur J Pharm Biopharm; 2008 Jun; 69(2):563-72. PubMed ID: 18294826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatially controlled delivery of neurotrophic factors in silk fibroin-based nerve conduits for peripheral nerve repair.
    Lin YC; Ramadan M; Hronik-Tupaj M; Kaplan DL; Philips BJ; Sivak W; Rubin JP; Marra KG
    Ann Plast Surg; 2011 Aug; 67(2):147-55. PubMed ID: 21712696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of tissue engineered nerve grafts and their application in peripheral nerve regeneration.
    Gu X; Ding F; Yang Y; Liu J
    Prog Neurobiol; 2011 Feb; 93(2):204-30. PubMed ID: 21130136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable systems and implantable conduits for peripheral nerve repair.
    Lin YC; Marra KG
    Biomed Mater; 2012 Apr; 7(2):024102. PubMed ID: 22456722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local delivery of glial cell line-derived neurotrophic factor improves facial nerve regeneration after late repair.
    Barras FM; Kuntzer T; Zurn AD; Pasche P
    Laryngoscope; 2009 May; 119(5):846-55. PubMed ID: 19266571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of lentiviral vector-mediated overexpression of nerve growth factor and glial cell line-derived neurotrophic factor on regenerating sensory and motor axons in the transected peripheral nerve.
    Tannemaat MR; Eggers R; Hendriks WT; de Ruiter GC; van Heerikhuize JJ; Pool CW; Malessy MJ; Boer GJ; Verhaagen J
    Eur J Neurosci; 2008 Oct; 28(8):1467-79. PubMed ID: 18973572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral nerve regeneration using composite poly(lactic acid-caprolactone)/nerve growth factor conduits prepared by coaxial electrospinning.
    Liu JJ; Wang CY; Wang JG; Ruan HJ; Fan CY
    J Biomed Mater Res A; 2011 Jan; 96(1):13-20. PubMed ID: 20949481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.